FilingSEC EDGAR8-K
20/20 Biolabs Adjourns Annual Meeting Regarding Charter Amendment Proposal
· SEC accepted
StageIn Progress
Filing content
The company completed director elections and other proposals but adjourned the meeting until September 16, 2026, for the charter amendment proposal due to insufficient votes.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…